A Randomized, Double-Blind, Phase III Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non–Small-Cell Lung Cancer After Disease Progression After 1 Previous Platinum-Based Therapy (REVEL): Treatment Rationale and Study Design
Edward B. Garon, Dachuang Cao, Ekaterine Alexandris, William J. John, Sergey Yurasov, Maurice PerolVolume:
13
Year:
2012
Language:
english
DOI:
10.1016/j.cllc.2012.06.007
File:
PDF, 264 KB
english, 2012